• Health & Medicine

What to expect - new photo guides for cancer treatment and scanning facilities

28 July 2010

• Health & Medicine

New molecular marker could predict if breast cancer patients need chemotherapy

A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists.

28 July 2010

• Health & Medicine

‘Molecular relay race’ at the heart of new targeted cancer therapy

Rather like a molecular relay race, the new treatment relies on a chain of events that culminates in the activation of a drug specifically in cancer cells. Rather like a molecular relay race, the new treatment relies on a chain of events that culminates in the activation of a drug specifically in cancer cells.

16 July 2010

• Science & Technology
• Health & Medicine

Highlights from the 2010 ASCO conference

8 June 2010

• Science & Technology
• Health & Medicine

Understanding triple negative breast cancer – 53BP1 and the BRCA1 connection

10 May 2010

• Health & Medicine

Making a impact in rarer cancers – the ABC02 trial

8 April 2010

• Science & Technology
• Health & Medicine

US researchers step closer to personalised cancer care

18 February 2010

• Health & Medicine

Combined chemotherapy and radiotherapy improves head and neck cancer survival

Cancer Research UK scientists have found that a combination of chemotherapy and radiotherapy improves survival from advanced head and neck cancer in patients who are not able to have surgery. Cancer Research UK scientists have found that a combination of chemotherapy and radiotherapy improves survival from advanced head and neck cancer in patients who are not able to have surgery.

30 October 2009

• Health & Medicine

UK scientists develop safer bone marrow transplant technique

Scientists have developed a new bone marrow transplant technique that only requires a small dose of chemotherapy and may therefore make treatment safer and less distressing for children with genetic defects in their immune system (primary immunodeficiencies or PID). Scientists have developed a new bone marrow transplant technique that only requires a small dose of chemotherapy and may therefore make treatment safer and less distressing for children with genetic defects in their immune system (primary immunodeficiencies or PID).

4 September 2009

• Health & Medicine

60-year-old drug shows new promise for inherited cancer

CANCER RESEARCH UK-funded scientists have shown that an early chemotherapy drug invented in the 1940s has the potential to work against a genetic fault called HNPCC* which is linked to bowel and other cancers. The results are published in EMBO Molecular Medicine** today, (Thursday). CANCER RESEARCH UK-funded scientists have shown that an early chemotherapy drug invented in the 1940s has the potential to work against a genetic fault called HNPCC* which is linked to bowel and other cancers. The results are published in EMBO Molecular Medicine** today, (Thursday).

27 August 2009

• Health & Medicine

Yeast 'DNA damage sensor' provides chemotherapy resistance clue

Cancer Research UK scientists have been part of an international collaboration that has revealed the structure of a protein found in simple yeast cells and shown how it flags up damaged DNA for repair. The results of their study are published in Nature* today (Thursday). The finding may provide clues as to how some cancer cells become resistant to certain chemotherapy drugs. Cancer Research UK scientists have been part of an international collaboration that has revealed the structure of a protein found in simple yeast cells and shown how it flags up damaged DNA for repair. The results of their study are published in Nature* today (Thursday). The finding may provide clues as to how some cancer cells become resistant to certain chemotherapy drugs.

11 June 2009

• Health & Medicine

Trial results show better survival for gallbladder and bile duct cancer

Combining two chemotherapy drugs for advanced gallbladder and bile duct cancer improves survival by a third, according to results from a Cancer Research UK funded trial presented today at the American Society of Clinical Oncology (ASCO) conference*. Combining two chemotherapy drugs for advanced gallbladder and bile duct cancer improves survival by a third, according to results from a Cancer Research UK funded trial presented today at the American Society of Clinical Oncology (ASCO) conference*.

2 June 2009